Effects of mirtazapine on levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Key Points

• Mirtazapine effectively decreases dyskinesia in a rat model of Parkinson's disease, promoting smoother motor function.
• In a rat model, treatment with mirtazapine led to a significant reduction of dyskinetic movements observed during levodopa administration.
• The analysis employed a rat model to observe the interactions between mirtazapine and levodopa on dyskinesia symptoms.
• This study highlights the potential of mirtazapine as an adjunctive treatment for managing dyskinesia in Parkinson's patients.